Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Morepen Laboratories LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500288NSE Symbol: MOREPENLABP/E(TTM):31.47
ISIN Demat:INE083A01026Div & Yield %:0EPS(TTM):1.59
Book Value(Rs):15.9655673Market Cap ( Cr.):2557.38Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 1338.881449.271112.42791.99717.24560.83
Excise Duty0.000.000.000.000.000.00
Net Sales1338.881449.271112.42791.99717.24560.83
Other Income 5.7610.2411.779.423.673.54
Stock Adjustments -16.54-1.7441.987.5819.46-4.24
Total Income1328.101457.771166.17808.99740.37560.13
EXPENDITURE :      
Raw Materials 886.48988.81778.60528.67485.82338.35
Power & Fuel Cost23.7818.9313.0012.5613.1811.08
Employee Cost 146.19150.00123.2098.0784.7468.22
Other Manufacturing Expenses 33.8123.3913.5710.549.476.35
Selling and Administration Expenses 111.6287.9082.3673.3767.3656.48
Miscellaneous Expenses 43.1949.3631.3011.8911.1115.83
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1245.081318.391042.03735.10671.68496.31
Operating Profit83.03139.37124.1573.8968.6963.80
Interest 1.98-7.371.791.972.074.29
Gross Profit81.05146.74122.3671.9266.6259.51
Depreciation18.0121.1928.1134.4338.0133.40
Profit Before Tax63.04125.5594.2537.4928.6126.11
Tax16.6022.000.005.150.000.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax0.202.480.000.000.000.00
Reported Net Profit46.24101.0694.2532.3328.6126.12
Extraordinary Items 0.000.000.000.000.000.00
Adjusted Net Profit46.24101.0694.2532.3328.6126.12
Adjst. below Net Profit 0.000.000.000.000.000.00
P & L Balance brought forward171.0374.96-19.29-51.62-80.23-106.35
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 0.005.000.000.000.000.00
P & L Balance carried down217.27171.0374.96-19.29-51.62-80.23
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %0.000.000.000.000.000.00
Earnings Per Share-Unit Curr0.902.122.100.720.640.58
Earnings Per Share(Adj)-Unit Curr0.902.122.100.720.640.58
Book Value-Unit Curr15.2611.978.926.836.175.57